Our Research
Discover our recent findings, catch up with news, and review in-depth resources.
Challenges of Developing an ADA Assay for Bispecific Antibody Therapeutics and ADA Characterization
Bispecifics (Bs) are biopharmaceutical products that bind to two different targets (epitopes). These are mainly two types: IgG-like (antibodies Abs) and non-IgG-like which include Bites (bispecific T-cell engager) and DARTs (Dual-affinity Re-targeting Antibody)…
What Makes a Good LC-MS/MS Bioassay?
Liquid chromatography linked to tandem mass spectrometry (LC–MS/MS, LC-MS) is the “go-to” method for pharmacokinetics and metabolism studies across drug development with recent advances in separation, throughput and methods for analyzing protein biotherapeutics…
Beyond the Abstract: An Interview with Ashley Phillips
In this Bioanalysis Zone podcast episode, our Senior Scientist and Technical Specialist Ashley Phillips discusses his recent publication…
A Step-by-Step Guide to Developing a Robust Assay in Bioanalysis Using LC-MS/MS
LC-MS/MS assay development within Bioanalysis is driven by developing accurate, precise and robust methods within the shortest time frame possible…
8 Essential Characteristics of LC-MS/MS Method Validation
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a powerful technique in the field of bioanalysis, and it plays a critical role in drug development and clinical trials…
Nitrosamines Analysis
How Resolian’s experienced team identifies and quantifies trace impurities in a diverse range of materials.
